Cargando…
Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection
BACKGROUND: Clostridium difficile infection (CDI) is an important cause of diarrhea and continues to be a major burden within healthcare institutions and in the community. For a small subset of patients with frequently relapsing CDI who do not have access to fecal microbiota transplantation (FMT), o...
Autores principales: | Zhang, Kevin, Beckett, Patricia, Abouanaser, Salaheddin, Stankus, Vida, Lee, Christine, Smieja, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332588/ https://www.ncbi.nlm.nih.gov/pubmed/30642269 http://dx.doi.org/10.1186/s12879-019-3676-1 |
Ejemplares similares
-
Initial vancomycin versus metronidazole for the treatment of first-episode non-severe Clostridioides difficile infection
por: Zhang, Kevin, et al.
Publicado: (2021) -
Prospective, Open-label Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Transplantation for Treatment of Recurrent C. difficile Infection
por: Goldeh, Peyman, et al.
Publicado: (2017) -
2415. Oral Vancomycin for Secondary Prophylaxis of Clostridium difficile Infections among High-risk Patients
por: Lew, Alison, et al.
Publicado: (2019) -
500. Efficacy of 30-Day Fidaxomicin for Treatment of Acute Clostridium difficile Infection With History of Multiple Recurrences
por: Lee, Christine, et al.
Publicado: (2018) -
Efficacy of Oral Vancomycin, Oral Metronidazole, or IV Metronidazole Prophylaxis at Reducing the Risk of Clostridium difficile Recurrence
por: O’Connell, Matthew, et al.
Publicado: (2017)